The Unseen Risk in a $23 Billion Company: What Generation Investment's Endorsement Means for West Pharmaceutical Services In a market dominated by a handful of stocks, savvy investors are seeking out quality companies that may have been overlooked.
One such company is West Pharmaceutical Services (WST), a $23 billion manufacturer and distributor of containment and delivery systems for injectable drugs and healthcare products.
Generation Investment Management's endorsement of WST suggests the firm believes the company has what it takes to thrive in a competitive industry.